Patrys Limited (ASX:PAB)
0.0390
0.00 (0.00%)
Jul 15, 2026, 10:07 AM AEST
Patrys Market Cap
Patrys has a market cap or net worth of 26 million as of July 14, 2026. Its market cap has increased by 531.83% in one year.
Market Cap
26.00M
Enterprise Value
24.09M
Revenue
100.38K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since July 13, 2007, Patrys's market cap has decreased from 97.06M to 26.00M, a decrease of -73.21%. That is a compound annual growth rate of -6.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 26.66M | 179.49% |
| Dec 31, 2025 | 9.54M | 15.93% |
| Dec 31, 2024 | 8.23M | -50.00% |
| Dec 29, 2023 | 16.46M | -70.36% |
| Dec 30, 2022 | 55.54M | -27.00% |
| Dec 31, 2021 | 76.08M | 75.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 50.00M |
| Imugene | 40.75M |
| Proteomics International Laboratories | 30.56M |
| Noxopharm | 27.34M |
| Algorae Pharmaceuticals | 25.32M |
| NeuroScientific Biopharmaceuticals | 21.62M |
| EZZ Life Science Holdings | 21.18M |
| Neurotech International | 21.08M |